Company Data

Design Therapeutics Inc.

Ticker
DSGN
Current Price
$4.87 17.92%
Market Cap
$275.7M
Price Target
Refer to Report
Volume
192.4K
52wk Range
$2.4501 - $7.77
Advanced Market Data

Overview

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy